Zetagen Therapeutics Raises Over $12M to Accelerate Breast-Cancer Pipeline
Zetagen Therapeutics, a clinical-stage biopharmaceutical company based in New York, has successfully raised over $12 million in Series B1 funding. Founded and led by CEO…
November 27







